Novartis AG is 49.4x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($283.13 B vs $5.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MIRM | NVS |
|---|---|---|
| Market cap | $5.73 B | $283.13 B |
| US-listed rank | #1294 | #47 |
| Revenue (latest FY) | $521.31M | - |
| Net income (latest FY) | -$23.36M | - |
| Net margin | -4.5% | - |
| SEC filings | 612 | 947 |
Novartis AG is 49.4x more valuable than Mirum Pharmaceuticals, Inc. by market capitalization ($283.13 B vs $5.73 B).
Full pages: Mirum Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.